Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Response to the letter by Wang et al.: Selumetinib for plexiform neurofibroma: Advances and ongoing challenges.

Author information

Affiliations

  • 1. Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
      Authors
    • Lee BH 1
    • Kim H 1
    (2 authors)
  • 2. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
      Authors
    • Yoon HM 2
    (1 author)

ORCIDs linked to this article

Neuro-oncology, 03 Oct 2024, :noae181
https://doi.org/10.1093/neuonc/noae181 PMID: 39362186 

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1093/neuonc/noae181

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.